bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Arcturus Therapeutics Inc. logo

    Arcturus Therapeutics Inc.

    ARCT | NASDAQ
    Chart Builder DCF Calculator
    $14.44
    -$0.25 (-1.70%)
    Sep 22, 2026, 2:37 PM ET · Market open
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $417.53M
    Enterprise Value
    $248.98M
    Beta
    2.48
    Average Volume
    713.93K
    Shares Outstanding (Diluted)
    28.42M
    Shares Change YoY
    4.77%
    Institutional Ownership
    85.46%
    Exchange
    NASDAQ
    ISIN
    US03969T1097

    Price Performance

    Price Change 1M
    10.2%
    Price Change 3M
    107.5%
    Price Change 6M
    108.1%
    Price Change YTD
    135.0%
    Price Change 1Y
    -30.1%
    Price Change 3Y
    -46.1%
    Price Change 5Y
    -71.0%
    1M CAGR (ann.)
    98.3%
    1Y CAGR (ann.)
    -25.1%
    5Y CAGR (ann.)
    -23.0%
    All-Time CAGR
    -9.2%

    Valuation

    PE Ratio
    -4.41
    Forward PE
    N/A
    PEG Ratio
    0.12
    Forward PEG
    -0.60
    PS Ratio
    17.54
    Forward PS
    20.30
    PB Ratio
    2.43
    P/FCF Ratio
    -4.51
    P/Adj. FCF Ratio
    -3.54
    P/OCF Ratio
    -5.74
    EV/Sales
    10.46
    EV/EBIT
    -2.93
    EV/EBITDA
    -3.00
    EV/FCF
    -2.69
    Earnings Yield
    -22.7%
    FCF Yield
    -22.1%
    Adj. FCF Yield
    -28.2%

    Financial Health

    Net Cash
    $191.48M
    Total Debt
    $22.93M
    Cash & Short-Term Investments
    $191.48M
    Total Assets
    $224.31M
    Current Ratio
    5.88
    Quick Ratio
    5.88
    Debt / Equity Ratio
    0.13
    Debt / EBITDA
    -0.28
    Debt / FCF
    -0.25
    OCF / Debt
    -4.02
    Interest Coverage
    0.00
    Altman Z-Score
    0.97
    Piotroski F-Score
    1

    Margins & Profitability

    Gross Profit Margin
    83.2%
    Operating Profit Margin
    -433.4%
    EBITDA Margin
    -348.4%
    Net Profit Margin
    -391.9%
    FCF Margin
    -388.6%
    Adj. FCF Margin
    -495.4%
    SBC / Revenue
    88.7%
    SBC Impact (per share)
    -27.5%

    Returns

    Return on Assets
    -41.6%
    Return on Equity
    -46.5%
    Return on Invested Capital
    -53.0%
    Return on Capital Employed
    -54.1%
    Return on Tangible Assets
    -41.6%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    -55.2%
    Revenue CAGR 5Y
    22.3%
    Revenue CAGR 10Y
    20.0%
    EPS CAGR 3Y
    -14.0%
    EPS CAGR 5Y
    3.5%
    EPS CAGR 10Y
    6.3%
    FCF CAGR 3Y
    -14.0%
    FCF CAGR 5Y
    -15.2%
    FCF CAGR 10Y
    -14.5%

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    21
    EPS Growth Next 3Y
    20.3%
    Revenue Growth Next 3Y
    65.3%
    Earnings Date
    Nov 8, 2026
    EPS Estimate (next Q)
    -$0.67
    EPS Growth Est (next Q)
    36.8%
    Revenue Est (next Q)
    $8M
    Revenue Growth Est (next Q)
    -53.4%

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $41
    Price Target Upside
    179.1%

    Cash Flow

    Operating Cash Flow
    $-92.17M
    Free Cash Flow
    $-92.49M
    Adj. Free Cash Flow
    $-117.92M
    FCF Per Share
    -$2.57
    OCF Per Share
    -$2.56
    OCF/S Ratio
    -305.6%

    Income Statement

    Revenue
    $23.8M
    Gross Profit
    $19.8M
    Operating Income
    $-103.14M
    EBITDA
    $-82.92M
    Net Income
    $-93.28M
    EPS (Diluted)
    -$3.33
    Revenue / Employee
    $218.36K
    Profit / Employee
    $-855.74K
    Employees
    109

    © 2026 bestshares.com. All rights reserved.